TAC1 and colorectal carcinoma: Antiproliferative effects of compounds 1 and 2 used for the treatment of cells derived from colorectal carcinomas were also demonstrated in connection with NKA and volume-regulated anion channels (VRAC), since after stimulation of NKA with CSs, VRAC is opened, cell volume is reduced, the consequence of which cell proliferation is inhibited.